Noble plc(NE)
Search documents
Snail, Inc. to Participate in Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference
GlobeNewswire News Room· 2024-11-22 14:00
CULVER CITY, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or “the Company”), a leading, global independent developer and publisher of interactive digital entertainment, today announced that its Co-Chief Executive Officer, Tony Tian, and Chief Financial Officer, Heidy Chow, will present at NobleCon20 - Noble Capital Markets’ Twentieth Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL, on Tuesday, Dece ...
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024
Newsfile· 2024-11-21 13:30
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024November 21, 2024 8:30 AM EST | Source: BioHarvest Sciences Inc.Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 21, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the Noble ...
Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference
GlobeNewswire News Room· 2024-11-21 13:30
NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will present at the upcoming Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference on December 3-4, 2024, in Boca Raton, FL. Noble Capital Markets’ 20th Annual Emerging Growth Equity ConferenceDates: December 3-4, 2024Location: Florida Atlantic Un ...
Silexion Therapeutics to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
GlobeNewswire News Room· 2024-11-20 13:30
GRAND CAYMAN, CAYMAN ISLANDS, Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced that the Company’s management will be attending and presenting at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference taking place December 3-4, 2024, in Boca Raton, Florida. Ilan Hadar, Chief Executive Officer will deliver a company presentation titled “Transforming Cancer C ...
Noble Corporation: Production Backlog And Capital Return Promising, Yet Low Visibility On Earnings Past 2025
Seeking Alpha· 2024-11-08 08:11
I only buy strong businesses. I only buy them when they're cheap. Backgrounds in economics, philosophy, government, data. I started my investing journey with a fairly concentrated portfolio of Canadian dividend payers in the telecom, pipeline and banking industries. I have moved forward through different industries including payments, US regional banking, Chinese and Brazilian equities, REITs, technology companies and a few other emerging market opportunities, as well as microcap through to megacap range. I ...
Noble plc(NE) - 2024 Q3 - Quarterly Report
2024-11-06 21:51
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________________________________ FORM 10-Q _____________________________________________________________________________________________________ ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ...
Noble plc(NE) - 2024 Q3 - Earnings Call Transcript
2024-11-06 16:05
Noble Corporation plc (NYSE:NE) Q3 2024 Earnings Conference Call November 6, 2024 9:00 AM ET Company Participants Ian MacPherson - Vice President of Investor Relations Robert Eifler - President and Chief Executive Officer Richard Barker - Chief Financial Officer Blake Denton - Senior Vice President of Marketing and Contracts Joey Kawaja - Senior Vice President of Operations Conference Call Participants Eddie Kim - Barclays Capital Kurt Hallead - Benchmark Greg Lewis - BTIG Fredrik Stene - Clarksons Securiti ...
Noble plc(NE) - 2024 Q3 - Earnings Call Presentation
2024-11-06 13:04
| --- | --- | |-----------------------------------------------------------------------------------------|-------| | | | | | | | Noble Corporation plc Third Quarter 2024 Earnings Conference Call November 6, 2024 | | Disclaimer Forward-Looking Statements This communication includes "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, as amended. All statements other than statements of historical facts included in this communication are forwa ...
Noble Corporation PLC (NE) Q3 Earnings Lag Estimates
ZACKS· 2024-11-06 00:30
Noble Corporation PLC (NE) came out with quarterly earnings of $0.58 per share, missing the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.87 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -36.96%. A quarter ago, it was expected that this company would post earnings of $0.61 per share when it actually produced earnings of $0.72, delivering a surprise of 18.03%.Over the last four quarters, the com ...
Noble plc(NE) - 2024 Q3 - Quarterly Results
2024-11-05 22:21
EXHIBIT 99.1 PRESS RELEASE NOBLE CORPORATION PLC ANNOUNCES THIRD QUARTER 2024 RESULTS AND ADDITIONAL SHARE REPURCHASE AUTHORIZATION • Closed Diamond acquisition on September 4th • Increased capital return program with additional share repurchase authorization of $400 million • Repurchased 6.9 million of shares in Q3 2024, $0.50 per share dividend declared for Q4 2024, bringing total FY 2024 cash returns to shareholders to over $525 million, including Q4 dividend • Q3 Net Income of $61 million, Diluted Earni ...